Literature DB >> 14044869

DAPSONE-INDUCED HAEMOLYSIS.

C D PENGELLY.   

Abstract

Entities:  

Keywords:  CHROMIUM ISOTOPES; DERMATITIS HERPETIFORMIS; HEMOLYSIS; SULFONES; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1963        PMID： 14044869      PMCID： PMC1872790          DOI： 10.1136/bmj.2.5358.662

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  13 in total

1.  Dapsone in the treatment of dermatitis herpetiformis.

Authors:  J O ALEXANDER
Journal:  Lancet       Date:  1955-06-11       Impact factor: 79.321

2.  Hemolytic anemia induced by sulfoxone therapy, with investigations into the mechanisms of its production.

Authors:  J F DESFORGES; W W THAYER; J P DAWSON
Journal:  Am J Med       Date:  1959-07       Impact factor: 4.965

3.  Heinz-body anaemia due to dapsone.

Authors:  R S SMITH; S ALEXANDER
Journal:  Br Med J       Date:  1959-03-07

4.  Five years of mass dapsone (DDS) treatment.

Authors:  A S GARRETT
Journal:  Lepr Rev       Date:  1956-04       Impact factor: 0.537

5.  Treatment of dermatitis herpetiformis with diamino-diphenyl-sulphone (D.D.S.).

Authors:  E E KRUIZINGA; H HAMMINGA
Journal:  Dermatologica       Date:  1953

6.  Correction for plasma trapped in the red cell column of the hematocrit.

Authors:  H CHAPLIN; P L MOLLISON
Journal:  Blood       Date:  1952-12       Impact factor: 22.113

7.  Dapsone treatment of leprosy.

Authors:  A S GARRETT; M G CORCOS
Journal:  Lepr Rev       Date:  1952 Jul-Oct       Impact factor: 0.537

8.  Haemolytic anaemia during treatment of leprosy with diaminodiphenylsulphone by mouth.

Authors:  K RAMANUJAM; M SMITH
Journal:  Lancet       Date:  1951-01-06       Impact factor: 79.321

9.  Four years' experience of sulphone treatment of leprosy.

Authors:  J LOWE; T F DAVEY
Journal:  Trans R Soc Trop Med Hyg       Date:  1951-06       Impact factor: 2.184

10.  The benzidine test for occult blood in faces.

Authors:  C D NEEDHAM; R G SIMPSON
Journal:  Q J Med       Date:  1952-04
View more
  7 in total

1.  Symptomatic hyperbilirubinemia secondary to dapsone-induced hemolysis and atazanavir therapy.

Authors:  Jeff East; Lucas Scott Blanton
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

2.  Antileprosy drugs.

Authors: 
Journal:  Br Med J       Date:  1971-07-17

Review 3.  Anaemia and skin disease.

Authors:  J Marks; S Shuster
Journal:  Postgrad Med J       Date:  1970-11       Impact factor: 2.401

4.  Reduction of excessive haematocrit levels in patients with polycythaemia due to hypoxic lung disease by phenylhydrazine hydrochloride and pyrimethamine.

Authors:  C D Pengelly
Journal:  Postgrad Med J       Date:  1969-09       Impact factor: 2.401

Review 5.  Clinical features and management of poisoning due to antimalarial drugs.

Authors:  A Jaeger; P Sauder; J Kopferschmitt; F Flesch
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug

6.  The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency.

Authors:  R L Degowin; R B Eppes; R D Powell; P E Carson
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

7.  N-hydroxylation of 4,4'-diaminodiphenylsulphone (Dapsone) by liver microsomes, and in dogs and humans.

Authors:  H Uehleke; S Tabarelli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.